Recombinant Shewanella woodyi Kynureninase (kynU)

Shipped with Ice Packs
In Stock

Description

Overview of Kynureninase (KYNU)

Kynureninase is a pyridoxal 5'-phosphate (PLP)-dependent enzyme that hydrolyzes L-kynurenine and L-3-hydroxykynurenine into anthranilic acid and 3-hydroxyanthranilic acid, respectively . It plays a critical role in the kynurenine pathway, which is central to tryptophan catabolism and NAD+ biosynthesis .

Recombinant Production of KYNU

Recombinant KYNU is typically expressed in E. coli or baculovirus systems with affinity tags (e.g., His-tag) for purification . For example:

  • Human KYNU: Expressed in E. coli (amino acids 1–307, GST-tagged) or baculovirus (amino acids 1–465, His-tagged) .

  • Activity: Specific activity >200 pmol/min/μg for 3-hydroxykynurenine oxidation .

Hypothetically, Shewanella woodyi KYNU would follow similar protocols, though no experimental data exists in the provided sources.

Biotechnological Applications

  • NAD+ Biosynthesis: KYNU is critical for NAD+ production, a cofactor in redox reactions .

  • Neuroimmunology: Bacterial KYNU homologs could model human enzymes linked to neurotoxicity (e.g., quinolinic acid) .

Research Limitations

  • No studies on Shewanella woodyi KYNU were identified in the provided sources.

  • Structural predictions would rely on homology modeling (e.g., using PfKyn PDB 2O4G) .

Key Research Findings from Homologous Systems

  • Inhibitor Design: Analogues of the gem-diolate intermediate (e.g., S-(2-aminophenyl)-L-cysteine S,S-dioxide) inhibit PfKyn (K<sub>i</sub> = 27 nM) .

  • Metabolite Detection: Recombinant KYNU activity is quantified via 3-hydroxyanthranilate accumulation (RFU/min/μg) .

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with blue ice packs by default. For dry ice shipping, contact us in advance; extra fees apply.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
kynU; Swoo_1405Kynureninase; EC 3.7.1.3; L-kynurenine hydrolase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-430
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Shewanella woodyi (strain ATCC 51908 / MS32)
Target Names
kynU
Target Protein Sequence
MIFENTLAFA QQQDRNDPLA HYSDQFHHPV IDGKEVLYFT GNSLGLQPKT AKEHINQELE DWAKWGVEGH FHAVNPWVSY HEILTPASAE LVGANESEVV CMNSLTTNLH LLFVSFYKPT AKRFKIISEA KMFPSDRYLL ETQVRHHGLD PDDAIIEISP REGEYLIREE DIIAAVNDNA DELALLFFGG VNYFTGQLFD MQRLTKAAHG VGALAGFDLA HAVGNVPMHL HDWDVDFAAW CTYKYLNSSA GNVGGIFVND RHGNNTKINR FGGWWGHNKE RRFLMENSFE PMTGAEGWQI SNAPVMGMAI LKSSLDIFHE AGIENLRAKS LKLTAYLEFV FNDIVNQFTD IKLEIITPTD PTQRGCQLSI KLVGTNKEFF EALTKAGVIA DFREPDVIRL APTPLYNSFE DVYLLGQTLK VLAQNWRQHG
Uniprot No.

Target Background

Function
Catalyzes the cleavage of L-kynurenine (L-Kyn) and L-3-hydroxykynurenine (L-3OHKyn) into anthranilic acid (AA) and 3-hydroxyanthranilic acid (3-OHAA), respectively.
Database Links
Protein Families
Kynureninase family

Q&A

What is Shewanella woodyi Kynureninase (kynU) and what is its primary function?

Shewanella woodyi Kynureninase (kynU) is an enzyme belonging to the PLP-dependent aspartate aminotransferase superfamily. In the kynurenine pathway, it primarily catalyzes the hydrolysis of 3-hydroxykynurenine (HKyn) to 3-hydroxyanthranilate (HAnt). This reaction represents the fourth step in the conversion of tryptophan to quinolinic acid (Qa), which is a precursor for NAD biosynthesis .

S. woodyi is notable among bacteria as it possesses both the complete kynurenine pathway and the Asp-DHAP pathway for Qa synthesis, suggesting potential metabolic versatility . The enzyme's physiological role is particularly important in the context of S. woodyi's marine adaptation and its bioluminescent properties .

What optimal conditions should be used for recombinant expression of S. woodyi kynureninase?

Based on general principles for expressing recombinant enzymes from marine bacteria and the specific nature of PLP-dependent enzymes, the following conditions are recommended:

ParameterRecommended ConditionRationale
Expression hostE. coli BL21(DE3) with codon optimizationCommon for heterologous expression; codon optimization addresses marine bacterial bias
Expression temperature16-20°CLower temperatures reduce inclusion body formation in PLP-dependent enzymes
Induction0.1-0.3 mM IPTG at OD600 ~0.6Moderate induction prevents aggregation
Media supplements50-100 μM pyridoxal phosphate (PLP)Ensures proper cofactor incorporation
Salt concentration2-3% NaClReflects native marine environment of S. woodyi
Purification bufferpH 7.5-8.0 with 5 mM PLPMaintains enzyme stability

Researchers should conduct small-scale optimization experiments varying these parameters to determine the specific conditions that yield the highest activity for their construct and expression system.

What methods are recommended for measuring S. woodyi kynureninase activity?

Several methodological approaches can be employed to measure kynureninase activity:

  • Spectrophotometric assay:

    • Monitor formation of 3-hydroxyanthranilate (HAnt) at 380 nm

    • Typical reaction conditions: 0.1 M potassium phosphate buffer (pH 7.5), 50 μM PLP, 0.2-1.0 mM substrate, 25-37°C

    • Calculate activity using HAnt's molar extinction coefficient (ε380 = 3,750 M⁻¹cm⁻¹)

  • HPLC-based quantification:

    • Use C18 reverse-phase column with gradient elution

    • Detect HKyn at 360 nm and HAnt at 320 nm

    • Calculate conversion rates based on peak areas

  • Coupled enzyme assay:

    • Link HAnt formation to 3-hydroxyanthranilate 3,4-dioxygenase (HADOX) reaction

    • Monitor formation of α-amino-β-carboxymuconic semialdehyde (ACMS) at 360 nm

The choice of method depends on available equipment, desired sensitivity, and specific experimental goals. For kinetic parameter determination, HPLC-based methods generally provide the most accurate results due to their ability to simultaneously quantify substrate consumption and product formation .

How is the kynurenine pathway regulated in S. woodyi compared to other bacteria?

The regulation of the kynurenine pathway in S. woodyi likely involves multiple mechanisms:

Regulatory FactorObserved EffectComparable System
Pathway redundancyPotential cross-regulation between Kyn and Asp-DHAP pathwaysUnique to species with dual pathways
Environmental factorsMarine conditions influence expression patternsSimilar adaptation in other marine bacteria
Tryptophan availabilityLikely induces pathway expressionSimilar to inducible systems in Pseudomonas
Growth phaseExpression patterns vary with cell densityMay relate to quorum sensing systems

S. woodyi possesses the complete kynurenine pathway alongside the Asp-DHAP pathway, which is unusual among bacteria . This dual pathway system suggests sophisticated regulatory mechanisms that might allow the organism to adapt to varying environmental conditions. Research examining transcriptional regulation under different growth conditions would provide valuable insights into this regulatory network.

What is the catalytic mechanism of S. woodyi kynureninase and how does it compare to other PLP-dependent enzymes?

The catalytic mechanism of S. woodyi kynureninase likely follows the general mechanism established for PLP-dependent enzymes in the aspartate aminotransferase superfamily, though specific details may vary:

  • Formation of internal aldimine: PLP forms a Schiff base with a conserved lysine residue in the enzyme active site

  • Transaldimination: Substrate displaces the lysine to form an external aldimine

  • C-α proton abstraction: Likely facilitated by the same lysine residue acting as a base

  • Hydration of ketone carbonyl: Forms gem-diolate intermediate

  • Elimination of anthranilate: Results from C-C bond cleavage

  • Formation of quinonoid intermediate: Through electron rearrangement

  • C-α reprotonation: Regenerates amino acid product

  • Hydrolysis and product release: Releases alanine and regenerates the internal aldimine

This mechanism is similar to the well-characterized P. fluorescens kynureninase, where a single residue (likely the PLP-binding lysine) mediates multiple steps as a general base catalyst .

The structure-function relationship in S. woodyi kynureninase would be particularly interesting to investigate given its marine origin and presence in a dual-pathway organism, which might have resulted in specific adaptations to its catalytic mechanism.

How do the kinetic parameters of S. woodyi kynureninase compare with kynureninases from other organisms?

While specific kinetic parameters for S. woodyi kynureninase require experimental determination, comparison with other characterized kynureninases provides a framework for understanding potential differences:

OrganismSubstrateKm (μM)kcat (s⁻¹)kcat/Km (M⁻¹s⁻¹)Reference
P. fluorescensKyn5.48.21.5 × 10⁶
P. fluorescensHKyn5057.91.6 × 10⁴
Human KYNSEKyn~200--
Human KYNSEHKyn~10--
S. woodyiKyn???-
S. woodyiHKyn???-

Given S. woodyi's dual pathway for NAD biosynthesis, its kynureninase might exhibit intermediate kinetic properties - potentially maintaining activity with both substrates but with less extreme preferences than observed in other bacteria or humans. The marine environment might also influence the enzyme's kinetic parameters, potentially showing different temperature or salt concentration dependencies compared to terrestrial bacterial enzymes .

What is the relationship between S. woodyi's bioluminescence mechanisms and its kynurenine pathway?

The potential relationship between S. woodyi's bioluminescence and its kynurenine pathway presents an intriguing research direction, though direct experimental evidence linking these processes remains to be established:

AspectPotential ConnectionResearch Approach
MetabolicNAD(P)H from kynurenine pathway-derived NAD may support bioluminescence reactionsMetabolic flux analysis with isotope labeling
RegulatoryQuorum sensing (swoI/swoR system) regulates luminescence and may affect kynurenine pathway Transcriptomics under varying cell densities
EvolutionaryDual pathway presence may reflect adaptation to bioluminescent lifestyleComparative genomics with non-luminescent Shewanella species
FunctionalKynurenine pathway products may influence cellular redox state affecting luminescenceGenetic knockout studies with metabolomics

S. woodyi MS32 has been identified as a luminous bacterium, with luminescence controlled by quorum sensing through the swoI and swoR genes . The potential regulatory overlap between luminescence mechanisms and metabolic pathways like the kynurenine pathway represents an exciting area for research into the integration of primary and secondary metabolism in bioluminescent bacteria.

How does the genomic context of the kynU gene in S. woodyi inform its function and regulation?

The genomic organization of the kynU gene and related genes in S. woodyi can provide important insights into its function and regulation:

  • Operon structure: Unlike the luminescence genes (luxCDABEG) which are regulated by swoR/swoI genes that originated from a separate horizontal gene transfer (HGT) , the kynurenine pathway genes may have a different evolutionary history and regulatory pattern.

  • Regulatory elements: Promoter analysis and identification of transcription factor binding sites upstream of kynU would reveal potential regulatory mechanisms.

  • Genomic neighborhood: The presence of both complete Kyn pathway genes and Asp-DHAP pathway genes in S. woodyi suggests potential co-regulation or metabolic channeling between these pathways .

  • Comparative genomics: Unlike the lux operon in S. woodyi which differs from closely related species like Shewanella hanedai in its genetic linkage to regulatory genes , the organization of kynurenine pathway genes might show different evolutionary patterns.

Understanding the genomic context of kynU would provide insights into how this enzyme functions within the broader metabolic network of S. woodyi and how its expression is coordinated with other cellular processes.

What structural features distinguish S. woodyi kynureninase and how do they impact enzyme function?

While the specific three-dimensional structure of S. woodyi kynureninase has not been reported, structural insights can be inferred from related enzymes and would be critical for understanding its function:

  • Domain organization: Like other aspartate aminotransferase superfamily members, S. woodyi kynureninase likely has a large domain containing PLP-binding residues and a small domain involved in substrate specificity .

  • Active site architecture: The positioning of catalytic residues, especially the PLP-binding lysine, would determine substrate specificity and reaction mechanism.

  • Substrate binding pocket: Structural features that accommodate the aromatic portion of the substrate would influence selectivity between Kyn and HKyn.

  • Conformational changes: Similar to human KYNSE, S. woodyi kynureninase likely undergoes substantial conformational rearrangement between open and closed states during catalysis .

  • Adaptations to marine environment: Potential structural features that enhance stability in high-salt conditions might be present, given S. woodyi's marine habitat .

Determining the crystal structure of S. woodyi kynureninase would be invaluable for comparative analysis with other kynureninases and for structure-based enzyme engineering efforts.

What approaches are most effective for engineering S. woodyi kynureninase for enhanced catalytic properties?

Several genetic engineering strategies could be employed to enhance the catalytic efficiency or alter the specificity of S. woodyi kynureninase:

Engineering ApproachSpecific TechniqueExpected Outcome
Rational designSite-directed mutagenesis of active site residuesAltered substrate specificity or increased catalytic rate
Directed evolutionError-prone PCR with activity-based screeningImproved stability or catalytic efficiency
Semi-rational designCombinatorial alanine scanning of binding pocketIdentification of critical residues for engineering
Structure-guided engineeringIntroduction of disulfide bridgesEnhanced thermostability
Domain swappingHybrid enzymes with other kynureninasesNovel substrate specificity

The effectiveness of these approaches would depend on:

  • Available structural information (homology models or crystal structures)

  • High-throughput screening methods for kynureninase activity

  • Clear definition of the desired improved properties

Combining rational design based on homology models with directed evolution approaches typically yields the most successful outcomes for enzyme engineering projects.

What are the best approaches for isolating and characterizing different strains of S. woodyi to study kynureninase diversity?

To effectively isolate and characterize S. woodyi strains for kynureninase diversity studies:

  • Isolation methodology:

    • Target marine environments, particularly from depths of 10-200m

    • Use selective media incorporating 2-3% NaCl

    • Screen for bioluminescence as an initial identification marker

    • Verify isolation through 16S rRNA gene sequencing

  • Strain characterization:

    • Analyze growth characteristics under various conditions

    • Assess enzymatic activities using standardized biochemical tests

    • Evaluate carbon and nitrogen source assimilation patterns

    • Determine antibiotic resistance profiles

  • Genomic diversity analysis:

    • Perform pulsed-field gel electrophoresis (PFGE) with restriction enzymes like SmaI and NotI

    • PFGE can reveal restriction fragment pattern homology ranging from 56-89% (SmaI) and 82-94% (NotI)

    • Sequence kynU genes from different isolates to assess polymorphism

  • Functional kynureninase characterization:

    • Express recombinant kynureninase from different strains

    • Compare kinetic parameters with standardized assays

    • Analyze thermal and pH stability profiles

This comprehensive approach would provide insights into the natural diversity of S. woodyi kynureninase and identify variants with potentially enhanced properties for biotechnological applications.

How can researchers effectively analyze the metabolic flux through the kynurenine pathway in S. woodyi?

Analyzing metabolic flux through the kynurenine pathway in S. woodyi requires a multi-faceted approach:

  • Isotope labeling studies:

    • Cultivate S. woodyi with 13C-labeled tryptophan

    • Track labeled carbons through pathway intermediates

    • Quantify flux ratios between kynurenine pathway and Asp-DHAP pathway

  • Metabolomics approach:

    • Extract and quantify all kynurenine pathway intermediates using LC-MS/MS

    • Compare metabolite pools under different growth conditions

    • Develop targeted methods for low-abundance intermediates

  • Gene expression analysis:

    • Monitor transcription of all kynurenine pathway genes using RT-qPCR

    • Perform RNA-seq to identify co-regulated genes

    • Correlate expression patterns with metabolite levels

  • Enzyme activity measurements:

    • Prepare cell-free extracts under different growth conditions

    • Measure activities of all kynurenine pathway enzymes

    • Identify potential rate-limiting steps

  • Mathematical modeling:

    • Develop kinetic models incorporating all enzymatic steps

    • Validate models with experimental data

    • Predict effects of genetic or environmental perturbations

This integrated approach would reveal how S. woodyi regulates flux through the kynurenine pathway versus the alternative Asp-DHAP pathway under different physiological conditions.

What are the critical control experiments needed when studying S. woodyi kynureninase activity in vitro?

When studying S. woodyi kynureninase activity in vitro, several critical control experiments should be included:

  • Enzyme quality controls:

    • Verify enzyme purity by SDS-PAGE (>95% homogeneity recommended)

    • Confirm PLP incorporation through absorbance spectra (typical peak at 420-430 nm)

    • Perform size exclusion chromatography to verify oligomeric state

  • Assay validation controls:

    • Include no-enzyme controls to account for spontaneous substrate degradation

    • Perform time-course measurements to ensure linearity during activity measurements

    • Verify product identity by HPLC or MS to confirm the expected reaction

  • Substrate specificity controls:

    • Test activity with both Kyn and HKyn under identical conditions

    • Include structurally related non-substrate analogues as negative controls

    • Verify enantiomeric specificity using D-stereoisomers

  • Cofactor dependency:

    • Assess activity with and without added PLP

    • Test the effects of PLP concentration on enzyme stability and activity

    • Evaluate potential inhibition by PLP analogues

  • Buffer composition controls:

    • Test activity across a range of pH values (typically pH 6.5-9.0)

    • Evaluate the effects of various buffer components

    • Assess salt concentration effects relevant to marine environment adaptation

Including these controls ensures that observed enzymatic activities are specifically attributable to S. woodyi kynureninase and provides context for interpreting experimental results.

How should researchers interpret contradictory kinetic data for S. woodyi kynureninase?

When facing contradictory kinetic data for S. woodyi kynureninase, researchers should systematically analyze potential sources of variation:

  • Methodological differences:

    • Compare assay methods used (spectrophotometric vs. HPLC-based)

    • Examine differences in reaction conditions (temperature, pH, ionic strength)

    • Assess enzyme preparation methods (expression system, purification protocol)

  • Enzyme state variations:

    • Evaluate PLP cofactor saturation levels

    • Check for potential oxidation of critical residues

    • Consider oligomeric state differences

  • Substrate quality:

    • Verify substrate purity and stability

    • Consider substrate solubility issues

    • Examine potential inhibitory contaminants

  • Mathematical model selection:

    • Re-analyze raw data using different kinetic models

    • Consider allosteric effects not captured by simple Michaelis-Menten kinetics

    • Evaluate substrate inhibition effects at high concentrations

  • Biological significance:

    • Consider physiological relevance of observed differences

    • Examine if contradictions reflect different functional states of the enzyme

    • Assess if S. woodyi's adaptation to marine environment creates unique kinetic properties

When reporting contradictory findings, researchers should clearly document all experimental conditions and consider performing standardized benchmark experiments to provide context for observed variations.

What computational methods can be used to predict substrate specificity of S. woodyi kynureninase?

Several computational approaches can be employed to predict substrate specificity of S. woodyi kynureninase:

  • Homology modeling:

    • Build structural models based on crystallized kynureninases (e.g., human or P. fluorescens)

    • Refine models through molecular dynamics simulations

    • Validate models using known biochemical data

  • Molecular docking:

    • Dock potential substrates into the active site model

    • Calculate binding energies and identify key interaction residues

    • Compare docking poses of Kyn versus HKyn

  • Quantum mechanics/molecular mechanics (QM/MM):

    • Model reaction mechanism with high-level quantum calculations

    • Identify transition states and energy barriers

    • Compare energetics for different potential substrates

  • Sequence-based machine learning:

    • Train models on known kynureninase sequences with experimentally determined specificities

    • Identify sequence features that correlate with substrate preference

    • Predict specificity of S. woodyi kynureninase based on these features

  • Molecular dynamics simulations:

    • Analyze substrate binding dynamics

    • Identify conformational changes upon substrate binding

    • Evaluate water accessibility to the active site

These computational predictions should be experimentally validated, ideally through site-directed mutagenesis of predicted specificity-determining residues followed by kinetic characterization.

What are the most promising applications for recombinant S. woodyi kynureninase in academic research?

Recombinant S. woodyi kynureninase offers several promising applications in academic research:

  • Metabolic engineering:

    • Engineering microorganisms for enhanced NAD production

    • Developing alternative routes for quinolinic acid synthesis

    • Creating biosensors for tryptophan metabolites

  • Comparative enzymology:

    • Studying evolutionary adaptations of PLP-dependent enzymes

    • Investigating how marine environments shape enzyme properties

    • Understanding substrate specificity determinants

  • Biocatalysis development:

    • Creating enantioselective biocatalysts for pharmaceutical intermediates

    • Developing enzyme cascades for complex transformations

    • Engineering kynureninase variants with novel specificities

  • Structural biology:

    • Investigating conformational dynamics of PLP-dependent enzymes

    • Studying protein adaptation mechanisms to marine environments

    • Analyzing protein-substrate interactions through crystallography

  • Cancer research:

    • Modulating kynurenine pathway metabolites in tumor microenvironments

    • Developing enzyme-based therapies for cancer treatment

    • Creating tools for studying tryptophan metabolism in cancer cells

Each of these applications would benefit from the unique properties of S. woodyi kynureninase, particularly its adaptation to the marine environment and its context within a dual-pathway organism.

How might S. woodyi kynureninase be engineered to function as a biocatalyst for pharmaceutical applications?

Engineering S. woodyi kynureninase for pharmaceutical biocatalysis would involve several strategic approaches:

  • Substrate scope expansion:

    • Engineer the binding pocket to accommodate non-natural substrates

    • Target synthesis of pharmaceutical intermediates requiring C-C bond cleavage

    • Modify selectivity to accept bulkier substrates

  • Operational stability enhancement:

    • Improve thermostability through consensus design or directed evolution

    • Engineer pH tolerance for compatibility with chemical process conditions

    • Enhance organic solvent tolerance for biphasic reaction systems

  • Immobilization optimization:

    • Develop covalent attachment strategies that preserve activity

    • Design enzyme variants with improved orientation for immobilization

    • Create fusion proteins for self-assembly on surfaces

  • Catalytic efficiency improvement:

    • Target rate-limiting steps through active site engineering

    • Enhance PLP binding for greater operational stability

    • Modify substrate access channels for improved kinetics

  • Process integration:

    • Engineer compatibility with continuous flow systems

    • Develop enzyme cascades incorporating kynureninase

    • Create whole-cell biocatalysts expressing optimized kynureninase variants

The marine origin of S. woodyi kynureninase might provide unique advantages, such as salt tolerance or stability properties, that could be beneficial in certain pharmaceutical manufacturing processes.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.